Santagata Davide: Timely Removal of Retrievable IVC Filters May Reduce VTE Recurrence and Mortality
Santagata Davide, Resident in Internal Medicine at University of Insubria, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Research and Practice in Thrombosis and Haemostasis (RPTH), adding:
“Pleased to share our new publication in Research and Practice in Thrombosis and Haemostasis:
‘Outcomes in Venous Thromboembolism with Retained versus Removed Inferior Vena Cava Filters: An Analysis from the RIETE Registry.’
In this RIETE Registry analysis of 1,186 patients with VTE receiving retrievable IVC filters, filter retention was associated with worse outcomes compared with filter removal.
Key findings:
- Higher VTE recurrence with retained filters: 7.5 percent versus 1.8 percent
- Recurrences were mainly driven by DVT.
- Filter removal was associated with lower adjusted risk of VTE recurrence
- All-cause mortality was higher in patients with retained filters: 17.0 percent versus 6.3 percent
- Major bleeding remained infrequent and was not significantly different between groups.
Clinical message: retrievable IVC filters require structured follow-up and timely removal whenever clinically feasible.
Grateful to Omri Cohen, Manuel Monreal, the RIETE investigators, and all co-authors for the collaboration.
The accompanying image was AI-generated – with supervision – to present the study on LinkedIn.”
Title: Outcomes in Venous Thromboembolism with Retained versus Removed Inferior Vena Cava Filters: An Analysis from the RIETE Registry
Authors: Omri Cohen, Davide Santagata, Gili Kenet, Juan José López-Núñez, My Hanh Bui, Andris Skride, Patricia López-Miguel, Raimundo Tirado, Fernando Arméstar, Manuel Monreal

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 21, 2026, 15:56Anita Zaidi: Why Only 2% of Health Research and Development Goes to Women’s Conditions
-
Sep 21, 2026, 15:49Omid Khalafi: Gating Strategy and How Do We Decide Which Cells to Analyze
-
Sep 21, 2026, 15:44Levacetylleucine: A New Therapeutic Approach to Ataxia Telangiectasia
-
Sep 21, 2026, 15:40Andreas Tridimas: The Diagnostic Traps of Lipaemic Blood – Why a Normal Amylase Can Mislead You
-
Sep 21, 2026, 15:33Arsene Mekinian: Exploring Cardiac Involvement in Behçet’s Disease
-
Sep 21, 2026, 15:23Anis Mahjoubi: MRI Findings of Krukenberg Tumors
-
Sep 21, 2026, 15:08Fikreab Tesfaye Tefera: 10 Practical Take-Home Points for Diagnosing Iron Deficiency Anemia
-
Sep 21, 2026, 14:10Aswin K Mohan: Lessons from TRANSCON 2026 – Building Resilient Blood Supply Systems Before Crisis Hits
-
Sep 21, 2026, 14:00Vincent Lu: Beyond PT and aPTT – How Hemostasis Evolves Across a Lifetime